Accuracy of CGM in the ICU, Compared to Standard of Care

• Conditions: Diabetes

• Registration Number: NCT04352907
• Lead Sponsor: University of British Columbia

Brief Summary

To determine the performance of the Dexcom CGM device in comparison to arterial glucose samples.

Detailed Description

The performance of the Dexcom continuous glucose sensor will be compared with the current standard of care which is arterial glucose samples analyzed on a glucose meter. Subjects will be ICU patients receiving intravenous insulin infusions.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2020-04-15
• Study First Submitted QC: 2020-04-15
• Study First Posted: 2020-04-20
• Study Start: 2020-11-06
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-31
• Last Update Posted: 2022-06-02
• Primary Completion: 2022-09
• Study Completion: 2022-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• minimum age 18 years
• anticipated to be on an insulin infusion for 3-7 consecutive days
• 10 of these subjects will be on vasopressors who will be receiving large volume fluid resuscitation

Read More

Exclusion Criteria

• subjects not on insulin infusion

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Continous Glucose Sensor values (CGM)	3 to 7 consecutive days	CGM will be compared with arterial glucose values

Secondary Outcome Measures

Name	Time	Method
Vasopressor Use	3 to 7 consecutive days	10 of the 20 subjects will be on vasopressors and large volume fluid resuscitation

Trial Locations

Locations (1)

Vancouver General Hospital; 🇨🇦 Vancouver, British Columbia, Canada